2020
DOI: 10.1097/gox.0000000000003153
|View full text |Cite
|
Sign up to set email alerts
|

Biopsy Results Are Not Sufficient to Exclude Breast Implant–associated Anaplastic Large Cell Lymphoma: A Case Mistaken for Disseminated Silicosis

Abstract: Summary We present a case report of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) that was mistaken as disseminated silicosis after multiple percutaneous biopsies. The correct diagnosis of BIA-ALCL was confirmed only after a pathologic examination of the capsulectomy specimens. A review of the literature of percutaneous biopsies of ALCL showed a diagnostic yield of only 63%. Although percutaneous biopsies may be facile to obtain and may be diagnostic, in our case, biopsies wer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
(12 reference statements)
0
1
0
Order By: Relevance
“…BIA-ALCL presents as a rapid and persistent unilateral or bilateral breast swelling, often along with breast discomfort and rarely with type-B symptoms. 59 In most cases, BIA-ALCL presents as a yellowish effusion fluid that is found between the breast implant and periprosthetic fibrous capsule ( Figure 6 A) and can be detected by imaging techniques such as ultrasound computed tomography or positron emission tomography-computed tomography (PET-CT) ( Figure 6 B). The effusion fluid is yellow in colour and opaque due to extensive tumour cell necrosis.…”
Section: Breast Implant-associated Lymphomamentioning
confidence: 99%
“…BIA-ALCL presents as a rapid and persistent unilateral or bilateral breast swelling, often along with breast discomfort and rarely with type-B symptoms. 59 In most cases, BIA-ALCL presents as a yellowish effusion fluid that is found between the breast implant and periprosthetic fibrous capsule ( Figure 6 A) and can be detected by imaging techniques such as ultrasound computed tomography or positron emission tomography-computed tomography (PET-CT) ( Figure 6 B). The effusion fluid is yellow in colour and opaque due to extensive tumour cell necrosis.…”
Section: Breast Implant-associated Lymphomamentioning
confidence: 99%